Patients with predicted PTC variants of FBN1 (leading to haploinsufficiency, quantitative defect) have more severe aortic dilatation and systemic manifestations than patients with predicted in-frame pathogenic variants (leading to a dominant negative effect, qualitative defect) [36, 39–46]. Here, FBN1 is linked to Vascular dilatation.